PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, USA.\', \'Biomedical Informatics Consultants LLC, Potomac, Maryland, USA.\', \'Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/dia.2020.0161
?:hasPublicationType
?:journal
  • Diabetes technology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32302499
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32302499>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32302499>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all